For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of Replimune Group Inc (NASDAQ: REPL) was $4.57 for the day, down -1.72% from the previous closing price of $4.65. In other words, the price has decreased by -$1.72 from its previous closing price. On the day, 2.53 million shares were traded. REPL stock price reached its highest trading level at $4.945 during the session, while it also had its lowest trading level at $4.56.
Ratios:
Our analysis of REPL’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 6.94 and its Current Ratio is at 6.94. In the meantime, Its Debt-to-Equity ratio is 0.23 whereas as Long-Term Debt/Eq ratio is at 0.21.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 15 ’25 when Hill Emily Luisa sold 9,154 shares for $5.37 per share. The transaction valued at 49,157 led to the insider holds 134,368 shares of the business.
Astley-Sparke Philip sold 32,279 shares of REPL for $260,169 on May 20 ’25. The Director now owns 1,405,071 shares after completing the transaction at $8.06 per share. On May 20 ’25, another insider, Xynos Konstantinos, who serves as the Chief Medical Officer of the company, sold 7,952 shares for $8.06 each. As a result, the insider received 64,093 and left with 146,933 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, REPL now has a Market Capitalization of 356715232 and an Enterprise Value of 29702216.
Stock Price History:
The Beta on a monthly basis for REPL is 0.69, which has changed by -0.5890288 over the last 52 weeks, in comparison to a change of 0.16845357 over the same period for the S&P500. Over the past 52 weeks, REPL has reached a high of $17.00, while it has fallen to a 52-week low of $2.68. The 50-Day Moving Average of the stock is -13.67%, while the 200-Day Moving Average is calculated to be -49.75%.
Shares Statistics:
REPL traded an average of 9.92M shares per day over the past three months and 2337990 shares per day over the past ten days. A total of 77.81M shares are outstanding, with a floating share count of 66.34M. Insiders hold about 15.01% of the company’s shares, while institutions hold 96.89% stake in the company. Shares short for REPL as of 1757894400 were 17276245 with a Short Ratio of 1.74, compared to 1755216000 on 19197338. Therefore, it implies a Short% of Shares Outstanding of 17276245 and a Short% of Float of 41.57.
Earnings Estimates
. The current assessment of Replimune Group Inc (REPL) involves the perspectives of 7.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is -$0.78, with high estimates of -$0.6 and low estimates of -$0.91.
Analysts are recommending an EPS of between -$2.85 and -$3.67 for the fiscal current year, implying an average EPS of -$3.2. EPS for the following year is -$2.01, with 6.0 analysts recommending between -$1.24 and -$2.97.
